Join to view full profile
10 Center Dr"# 13N202"Bethesda, MD 20892
Phone+1 301-496-6770
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Isaac Brownell, MD is a board certified dermatologist in Bethesda, Maryland. He is currently licensed to practice medicine in New York.
Education & Training
NYU Grossman School of MedicineResidency, Dermatology, 2004 - 2007
St. Joseph Medical CenterInternship, Transitional Year, 2003 - 2004
Baylor College of MedicineClass of 2003
Certifications & Licensure
NY State Medical License 2004 - 2028
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 4 citationsA Comparative Study of Merkel Cell Carcinoma and Melanoma Incidence and Survival in the United States, 2000-2021.Jacob T Tribble, Isaac Brownell, Elizabeth K Cahoon, Michael R Sargen, Meredith S Shiels
The Journal of Investigative Dermatology. 2025-08-01 - 23 citationsNovel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial.Charalampos S Floudas, Meghali Goswami, Renee N Donahue, Danielle M Pastor, Jason M Redman
JAMA Oncology. 2025-04-01 - 2 citationsA multivariable disease-specific model enhances prognostication beyond current Merkel cell carcinoma staging: An international cohort study of 10,958 patients.Tom W Andrew, Sophie Erdmann, Mogdad Alrawi, Ruth Plummer, Sophia Z Shalhout
Journal of the American Academy of Dermatology. 2025-03-01
Authored Content
- Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung TransplantMay 2020
- Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung TransplantMay 2020
Press Mentions
Society for Immunotherapy of Cancer (SITC) Publishes Clinical Practice Guideline on Immunotherapy for the Treatment of Nonmelanoma Skin CancerAugust 3rd, 2022- Study Adds to Debate About Screening for MelanomaMay 4th, 2022
- Basal Cell Carcinoma Preferentially Arises from Stem Cells Within Hair Follicle and Mechanosensory NichesApril 2nd, 2020
Grant Support
- Molecular pathogenesis and therapy innovation for Merkel cell carcinomaNATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESPresent
- Investigation of skin cancer and skin diseaseNATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESPresent
- Molecular pathogenesis and therapy innovation for Merkel cell carcinomaNATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESPresent
- Development and regulation of stem cell lineages in skinNATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESPresent
- Clinical treatment of advanced Merkel cell carcinomaNATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESPresent
